Other synthetic lethal partners that have been identified through RNAi screening within an activated KRAS background include STK33, TBK1, WT1, CDK1, CDK4, GATA2, and Snail2, studies conducted primarily using colon and lung cancer cells [58–64]. This evidence concerns the gene KRAS and lung cancer.